This book provides an in-depth exploration of Continuous Glucose Monitoring (CGM), covering accuracy metrics, glycemic data interpretation, clinical applications, and recent advancements. It is an essential guide for researchers, clinicians, and students in diabetes management, biomedical science, and engineering.
This book provides an in-depth exploration of Continuous Glucose Monitoring (CGM), covering accuracy metrics, glycemic data interpretation, clinical applications, and recent advancements. It is an essential guide for researchers, clinicians, and students in diabetes management, biomedical science, and engineering.
Laura Solano teaches genetics at A.T. Still University, USA. She graduated from the University of North Texas Health Sciences with a master's in physician assistant studies. She has practiced faithfully in primary care for over a decade. In 2022, she graduated from A.T. Still University with a Doctorate in Medical Sciences and has published several research and education articles.
Inhaltsangabe
Contents Preface.......................................................................................................................ix Acknowledgments......................................................................................................x Chapter 1 History of CGMs..................................................................................1 Chapter 2 Technology .........................................................................................10 Chapter 3 Accuracy.............................................................................................17 Chapter 4 Data Interpretation and Ambulatory Glucose Profile .........................25 Chapter 5 OTC CGMs ........................................................................................32 Chapter 6 Prescription CGM Indications............................................................36 Chapter 7 Efficacy...............................................................................................39 Chapter 8 Billing and Coding .............................................................................46 Chapter 9 Adverse Effects and Interfering Substances.......................................52 Chapter 10 Adoption and Barriers........................................................................56 Chapter 11 Disparities...........................................................................................62 Chapter 12 Insurance Coverage Complexities......................................................64 Chapter 13 Privacy of CGM Data.........................................................................66 Chapter 14 AI + CGM ..........................................................................................70 Chapter 15 Fitness, Athletes, and CGMs..............................................................73 Chapter 16 Research on Psychiatric Effects of CGMs.........................................77 Chapter 17 Controversy ........................................................................................79 Chapter 18 Case Studies .......................................................................................81 Chapter 19 Future Directions................................................................................85 Index........................................................................................................................89
